Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
FDA Orange Book
0
Canada
0
Australia
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Bentyl
2. Bentylol
3. Di Cyclonex
4. Di Spaz
5. Di-cyclonex
6. Di-spaz
7. Dibent
8. Diclomin
9. Dicyclomine Hydrochloride
10. Dicycloverin
11. Hydrochloride, Dicyclomine
12. Lomine
13. Merbentyl
14. Or Tyl
15. Or-tyl
16. Spascol
1. Dicycloverine
2. Dicycloverin
3. 77-19-0
4. Bentyl
5. Diocyl
6. Di-syntramine
7. Bentylol
8. Dicicloverina
9. Wyovin
10. Dicycloverinum
11. Dicymine
12. Procyclomin
13. Bentomine
14. Mamiesan
15. Sawamin
16. Atumin
17. Dyspas
18. 2-(diethylamino)ethyl 1-cyclohexylcyclohexane-1-carboxylate
19. Oxityl-p
20. Kolantyl
21. Diocyl Hydrochloride
22. Wyovin Hydrochloride
23. Dicycloverin Hydrochloride
24. Dicycloverine (inn)
25. [1,1'-bicyclohexyl]-1-carboxylic Acid, 2-(diethylamino)ethyl Ester
26. (bicyclohexyl)-1-carboxylic Acid, 2-(diethylamino)ethyl Ester
27. (1,1'-bicyclohexyl)-1-carboxylic Acid, 2-(diethylamino)ethyl Ester
28. 4kv4x8if6v
29. Chembl1123
30. 2-(diethylamino)ethyl 1-cyclohexylcyclohexanecarboxylate
31. 2-(diethylamino)ethyl 1,1'-bi(cyclohexyl)-1-carboxylate
32. Chebi:4514
33. Bicyclohexyl-1-carboxylic Acid 2-diethylamino-ethyl Ester
34. Ncgc00015368-06
35. Diethylaminocarbethoxybicyclohexyl Hydrochloride
36. Dicycloverinum [inn-latin]
37. Dicicloverina [inn-spanish]
38. Dsstox_cid_2926
39. Dicycloverine [inn]
40. Dsstox_rid_76790
41. Dsstox_gsid_22926
42. Bentyl Hydrochloride
43. Bentylol; Dicyclomine; Dicycloverin; Dicycloverine
44. Bentylol Hydrochloride
45. Dicycloverine [inn:ban]
46. Cas-77-19-0
47. Dicymine (tn)
48. Dicyclomine [inn]
49. Hsdb 3058
50. Einecs 201-009-4
51. Unii-4kv4x8if6v
52. Bicyclohexyl-1-carbonsaeure-2'diethylaminoethylester
53. Byclomine
54. [bicyclohexyl]-1-carboxylic Acid, 2-(diethylamino)ethyl Ester
55. Bis(cyclohexyl)carboxylic Acid Diethylaminoethyl Ester Hydrochloride
56. 2-diethylaminoethyl 1-cyclohexylcyclohexane-1-carboxylate
57. Spectrum_000934
58. Dicyclomine [mi]
59. Prestwick0_000048
60. Prestwick1_000048
61. Prestwick2_000048
62. Prestwick3_000048
63. Spectrum2_000590
64. Spectrum3_000388
65. Spectrum4_000509
66. Spectrum5_000873
67. Lopac-d-7909
68. Dicyclomine [hsdb]
69. Dicyclomine [vandf]
70. Dicycloverine (dicyclomine)
71. Schembl3317
72. Lopac0_000432
73. Bspbio_000175
74. Bspbio_002175
75. Gtpl355
76. Kbiogr_001057
77. Kbioss_001414
78. Divk1c_000162
79. Spbio_000440
80. Spbio_002096
81. Dicycloverine [who-dd]
82. Bpbio1_000193
83. Dtxsid1022926
84. Curutkgfnzgfse-uhfffaoysa-
85. Hy-b1339a
86. Kbio1_000162
87. Kbio2_001414
88. Kbio2_003982
89. Kbio2_006550
90. Kbio3_001395
91. Ninds_000162
92. Hms3604h12
93. Zinc1530613
94. Tox21_113571
95. 2-diethylaminoethyl 1-cyclohexylcyclohexane-1-carboxylate Hydrochloride
96. Bdbm50010101
97. Nsc404381
98. Stl356799
99. [bicyclohexyl]-1-carboxylic Acid, 2-(diethylamino)ethyl Ester Hydrochloride
100. Akos022107181
101. Tox21_113571_1
102. Ccg-204524
103. Db00804
104. Sdccgsbi-0050417.p005
105. Cas-67-92-5
106. Idi1_000162
107. Ncgc00015368-01
108. Ncgc00015368-02
109. Ncgc00015368-03
110. Ncgc00015368-04
111. Ncgc00015368-05
112. Ncgc00015368-07
113. Ncgc00015368-08
114. Ncgc00015368-11
115. Ncgc00015368-17
116. Ncgc00016300-01
117. Ncgc00024386-03
118. Ncgc00024386-04
119. Sbi-0050417.p004
120. Ab00053456
121. Cs-0013567
122. Wln: L6tj A- Al6tj Avo2n2&2 &gh
123. (bicyclohexyl)-1-carboxylic Acid, Hydrochloride
124. C06951
125. D07820
126. [1, 2-(diethylamino)ethyl Ester, Hydrochloride
127. Ab00053456_14
128. Ab00053456_15
129. L000680
130. Q2662662
131. 2-diethylaminoethyl 1-cyclohexylcyclohexanecarboxylate
132. Brd-k68507560-003-05-5
133. Brd-k68507560-003-15-4
134. 2-(diethylamino)ethyl (bicyclohexyl)-1-carboxylate
135. .beta.-diethylaminoethyl-1-cyclohexylhexahydrobenzoate Hydrochloride
136. .beta.-diethylaminoethyl 1-cyclohexylcyclohexanecarboxylate Hydrochloride
137. 104959-55-9
| Molecular Weight | 309.5 g/mol |
|---|---|
| Molecular Formula | C19H35NO2 |
| XLogP3 | 5.5 |
| Hydrogen Bond Donor Count | 0 |
| Hydrogen Bond Acceptor Count | 3 |
| Rotatable Bond Count | 8 |
| Exact Mass | 309.266779359 g/mol |
| Monoisotopic Mass | 309.266779359 g/mol |
| Topological Polar Surface Area | 29.5 Ų |
| Heavy Atom Count | 22 |
| Formal Charge | 0 |
| Complexity | 326 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
| 1 of 2 | |
|---|---|
| Drug Name | Bentyl |
| PubMed Health | Dicyclomine |
| Drug Classes | Gastrointestinal Agent |
| Drug Label | Dicyclomine hydrochloride is an antispasmodic and anticholinergic (antimuscarinic) agent available in the following dosageforms:Dicyclomine Hydrochloride Capsules, USP for oral use contain 10 mg dicyclomine hydrochloride, USP. Dicyclomine hydroch... |
| Active Ingredient | Dicyclomine hydrochloride |
| Dosage Form | Injectable; Tablet; Syrup; Capsule |
| Route | Injection; Oral |
| Strength | 10mg/5ml; 10mg; 10mg/ml; 20mg |
| Market Status | Prescription |
| Company | Aptalis Pharma Us; Forest Labs |
| 2 of 2 | |
|---|---|
| Drug Name | Bentyl |
| PubMed Health | Dicyclomine |
| Drug Classes | Gastrointestinal Agent |
| Drug Label | Dicyclomine hydrochloride is an antispasmodic and anticholinergic (antimuscarinic) agent available in the following dosageforms:Dicyclomine Hydrochloride Capsules, USP for oral use contain 10 mg dicyclomine hydrochloride, USP. Dicyclomine hydroch... |
| Active Ingredient | Dicyclomine hydrochloride |
| Dosage Form | Injectable; Tablet; Syrup; Capsule |
| Route | Injection; Oral |
| Strength | 10mg/5ml; 10mg; 10mg/ml; 20mg |
| Market Status | Prescription |
| Company | Aptalis Pharma Us; Forest Labs |
Muscarinic Antagonists; Parasympatholytics
National Library of Medicine's Medical Subject Headings online file (MeSH, 1999)
...OFTEN CLASSIFIED WITH ANTIMUSCARINIC AGENTS AS "ANTISPASMODICS," DO NOT PROPERLY BELONG TO GROUP OF ANTIMUSCARINIC AGENTS. ...DICYCLOMINE HYDROCHLORIDE, VSP-DECR SPASM OF GI TRACT, BILIARY TRACT, URETER, & UTERUS WITHOUT PRODUCING CHARACTERISTIC ATROPINIC EFFECTS ON SALIVARY, SWEAT, OR GI GLANDS, EYE, CV SYSTEM... /HCL/
Goodman, L.S., and A. Gilman. (eds.) The Pharmacological Basis of Therapeutics. 5th ed. New York: Macmillan Publishing Co., Inc., 1975., p. 527
IT DECR MOTILITY BUT DOES NOT SUPPRESS GASTRIC SECRETION. IT IS USED IN TREATMENT OF IRRITABLE COLON, SPASTIC CONSTIPATION, MUCOUS COLITIS, SPASTIC COLITIS, PYLOROSPASM, & BILIARY DYSKINESIA. IN TREATMENT OF PEPTIC ULCER IT IS USED TO DELAY GASTRIC EMPTYING. /HYDROCHLORIDE/
Osol, A. and J.E. Hoover, et al. (eds.). Remington's Pharmaceutical Sciences. 15th ed. Easton, Pennsylvania: Mack Publishing Co., 1975., p. 844
ANTICHOLINERGIC /HYDROCHLORIDE/
The Merck Index. 9th ed. Rahway, New Jersey: Merck & Co., Inc., 1976., p. 409
DICYCLOMINE SHOULD BE USED CAUTIOUSLY IN PT WITH PROSTATIC HYPERTROPHY, BLADDER NECK OBSTRUCTION, PYLORIC OBSTRUCTION, & CARDIOSPASM. EVEN THOUGH IT DOES NOT APPEAR TO RAISE INTRAOCULAR PRESSURE IN NARROW-ANGLE GLAUCOMA, IT IS ADVISABLE TO MONITOR PRESSURE OF SUCH PT.
Osol, A. and J.E. Hoover, et al. (eds.). Remington's Pharmaceutical Sciences. 15th ed. Easton, Pennsylvania: Mack Publishing Co., 1975., p. 844
CLINICAL USE OF.../BENTYL/ HAS BEEN DISAPPOINTING.
Goodman, L.S., and A. Gilman. (eds.) The Pharmacological Basis of Therapeutics. 5th ed. New York: Macmillan Publishing Co., Inc., 1975., p. 527
A 3-YR-OLD MALE INGESTED APPROX 100 TABLETS OF BENDECTIN & DEVELOPED TONIC-CLONIC SEIZURES FOLLOWED BY CARDIAC ARREST. ANALYSIS YIELDED HIGH LEVELS OF DOXYLAMINE, DICYCLOMINE & PYRIDOXINE. DOXYLAMINE APPEARS TO BE TOXIC CONSTITUENT.
BAYLEY M ET AL; FATAL OVERDOSE FROM BENDECTIN; CLIN PEDIATR (PHILA) 14: 507 (1975)
Dicyclomine is indicated for the treatment of functional bowel disorder and irritable bowel syndrome.
FDA Label
Dicyclomine is an anticholinergic drug used to relax the smooth muscles of the intestines. It's duration of action is not especially long as it is usually taken 4 times daily with individual doses of 20-40mg orally or 10-20mg by intramuscular injection. Dicyclomine should not be administered intravenously.
Parasympatholytics
Agents that inhibit the actions of the parasympathetic nervous system. The major group of drugs used therapeutically for this purpose is the MUSCARINIC ANTAGONISTS. (See all compounds classified as Parasympatholytics.)
Muscarinic Antagonists
Drugs that bind to but do not activate MUSCARINIC RECEPTORS, thereby blocking the actions of endogenous ACETYLCHOLINE or exogenous agonists. Muscarinic antagonists have widespread effects including actions on the iris and ciliary muscle of the eye, the heart and blood vessels, secretions of the respiratory tract, GI system, and salivary glands, GI motility, urinary bladder tone, and the central nervous system. (See all compounds classified as Muscarinic Antagonists.)
A - Alimentary tract and metabolism
A03 - Drugs for functional gastrointestinal disorders
A03A - Drugs for functional gastrointestinal disorders
A03AA - Synthetic anticholinergics, esters with tertiary amino group
A03AA07 - Dicycloverine
Absorption
The bioavailability of dicyclomine has not been determined, though it is likely well absorbed as the primary route of elimination is in the urine. Dicyclomine has a Tmax of 1-1.5h.
Route of Elimination
Dicyclomine is 79.5% eliminated in the urine and 8.4% in the feces.
Volume of Distribution
The volume of distribution for a 20mg oral dose is 3.65L/kg.
Clearance
Data regarding the clearance of dicyclomine is not readily available.
The metabolism of dicyclomine has not been well researched.
The mean plasma elimination half life is approximately 1.8 hours.
Dicyclomine achieves its action partially through direct antimuscarinic activity of the M1, M3, and M2 receptors; and partially through antagonism of bradykinin and histamine. Dicyclomine non-competitively inhibits the action of bradykinin and histamine, resulting in direct action on the smooth muscle, and decreased strength of contractions seen in spasms of the ileum.
...MAJOR ACTION APPEARS TO BE NONSPECIFIC DIRECT RELAXANT ACTION ON SMOOTH MUSLCE RATHER THAN COMPETITIVE ANTAGONISM OF ACH.
Goodman, L.S., and A. Gilman. (eds.) The Pharmacological Basis of Therapeutics. 5th ed. New York: Macmillan Publishing Co., Inc., 1975., p. 527
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
| Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
|---|
Upgrade, download data, analyse, strategize, subscribe with us 
FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Europe
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Related Excipient Companies
Rochem International Inc
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]SPI Pharma
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Faran Shimi Pharmaceutical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Gangwal Healthcare
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Nanjing Well Pharmaceutical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Pfanstiehl
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Actylis
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Anhui Sunhere Pharmaceutical Excipients Co.,Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]DFE Pharma
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Gangwal Chemicals
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Ingredion Pharma Solutions
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Kerry
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Microlex e.U
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Nitika Pharmaceutical Specialities
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Pluviaendo
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Prachin Chemical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Roquette
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Seppic
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Shanghai Shenmei Pharmaceutical Technology Co., Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Sigachi Industries
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Excipients by Applications
Fillers, Diluents & Binders
Lubricants & Glidants
Direct Compression
Taste Masking
Granulation
Co-Processed Excipients
Thickeners and Stabilizers
Parenteral
Coating Systems & Additives
Disintegrants & Superdisintegrants
Chewable & Orodispersible Aids
Emulsifying Agents
API Stability Enhancers
Controlled & Modified Release
Digital Content
NEWS #PharmaBuzz
Global Sales Information
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
63
PharmaCompass offers a list of Dicyclomine API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Dicyclomine manufacturer or Dicyclomine supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Dicyclomine manufacturer or Dicyclomine supplier.
PharmaCompass also assists you with knowing the Dicyclomine API Price utilized in the formulation of products. Dicyclomine API Price is not always fixed or binding as the Dicyclomine Price is obtained through a variety of data sources. The Dicyclomine Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A NCGC00024386-03 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of NCGC00024386-03, including repackagers and relabelers. The FDA regulates NCGC00024386-03 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. NCGC00024386-03 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of NCGC00024386-03 manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A NCGC00024386-03 supplier is an individual or a company that provides NCGC00024386-03 active pharmaceutical ingredient (API) or NCGC00024386-03 finished formulations upon request. The NCGC00024386-03 suppliers may include NCGC00024386-03 API manufacturers, exporters, distributors and traders.
click here to find a list of NCGC00024386-03 suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
NCGC00024386-03 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of NCGC00024386-03 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right NCGC00024386-03 GMP manufacturer or NCGC00024386-03 GMP API supplier for your needs.
A NCGC00024386-03 CoA (Certificate of Analysis) is a formal document that attests to NCGC00024386-03's compliance with NCGC00024386-03 specifications and serves as a tool for batch-level quality control.
NCGC00024386-03 CoA mostly includes findings from lab analyses of a specific batch. For each NCGC00024386-03 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
NCGC00024386-03 may be tested according to a variety of international standards, such as European Pharmacopoeia (NCGC00024386-03 EP), NCGC00024386-03 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (NCGC00024386-03 USP).
